What's happening
This bill requires health insurance policies in New York to cover diagnostic testing for ovarian cancer for certain women at higher risk.
Why it matters
Targets higher-risk women. The bill specifically extends coverage to women aged 40 or older who have at least one female relative with a history of ovarian cancer, addressing a group with statistically higher risk and potentially improving early detection rates.
Mandates comprehensive diagnostic options. Insurance policies must cover not just a single test, but a range of diagnostic procedures—including pelvic exams, sonograms, CA 125 blood tests, and related laboratory services—ensuring more thorough evaluation for ovarian cancer.
Reduces financial barriers for early detection. By requiring insurers to cover these diagnostic tests (subject to usual deductibles and coinsurance), the bill aims to reduce out-of-pocket costs that might otherwise prevent at-risk women from seeking early screening and diagnosis.
Standardizes coverage across insurance types. The mandate applies to a wide variety of health insurance plans (including hospital, medical expense indemnity, and health service corporations), promoting more consistent access to ovarian cancer diagnostics regardless of the specific plan a woman holds.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Cover Ovarian Cancer Testing
Plain English, a few words. Used as the page title.
Sponsors
History
- Referred to insurance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Cover Ovarian Cancer Testing
In Assembly Committee · Insurance · Sponsor J. Gary Pretlow
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
4832
2021-2022 Regular Sessions
IN SENATE
February 16, 2021
Introduced by Sen. BIAGGI -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance
AN ACT to amend the insurance law, in relation to health insurance coverage for diagnostic testing for ovarian cancer
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 11-b to read as follows:
(11-b) (A) Every policy delivered or issued for delivery in this state which provides medical coverage that includes coverage for physician services in a physician's office and every policy which provides major medical or similar comprehensive-type coverage shall provide, upon the prescription of a health care provider legally authorized to prescribe under title eight of the education law, coverage for diagnostic testing for ovarian cancer, including a pelvic examination, a sonogram, a CA 125 blood test and laboratory and diagnostic services provided in connection with examining and evaluating such blood test for women aged forty and over with one or more female relatives with a prior history of ovarian cancer.
(B) Such coverage may be subject to annual deductibles and coinsurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy.
§ 2. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 11-b to read as follows:
(11-b) (A) Every insurer which delivers or issues for delivery in this state a policy which provides medical coverage that includes coverage for physician services in a physician's office or major medical or similar comprehensive-type coverage shall provide, upon the prescription of a health care provider legally authorized to prescribe under title eight of the education law, coverage for diagnostic testing for ovarian cancer, including a pelvic examination, a sonogram, a CA 125 blood test
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00238-01-1
S. 4832 2
and laboratory and diagnostic services provided in connection with examining and evaluating such blood test for women aged forty and over with one or more female relatives with a prior history of ovarian cancer.
(B) Such coverage may be subject to annual deductibles and coinsurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy.
§ 3. Section 4303 of the insurance law is amended by adding a new subsection (ss) to read as follows:
(ss) (1) A hospital service corporation, medical expense indemnity corporation or health service corporation which provides medical coverage that includes coverage for physician services in a physician's office or major medical or similar comprehensive-type coverage shall provide, upon the prescription of a health care provider legally authorized to prescribe under title eight of the education law, coverage for diagnostic testing for ovarian cancer, including a pelvic examination, a sonogram, a CA 125 blood test and laboratory and diagnostic services provided in connection with examining and evaluating such blood test for women aged forty and over with one or more female relatives with a prior history of ovarian cancer.
(2) Such coverage may be subject to annual deductibles and coinsurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy.
§ 4. This act shall take effect on the first of January next succeeding the date on which it shall have become a law and shall apply to all policies issued, renewed, altered or modified on or after such effective date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the insurance law, in relation to health insurance coverage for diagnostic testing for ovarian cancer
Purpose
To have every health insurance policy which provides coverage for hospi- tal, surgical or medical care shall provide coverage for diagnostic testing for ovarian cancer.
Summary of specific provisions
Section 1 amends subsection (i) of section 3216 of the insurance law by adding a new paragraph 11-b to which requires every policy in this state providing medical coverage to carry coverage for ovarian cancer testing and screening.
Section 2 amends subsection (1) of section 3221 of the insurance law by adding a new paragraph 11-b to which requires every insurer in this state providing medical coverage to carry coverage for ovarian cancer testing and screening.
Section 3 amends section 4303 of the insurance law by adding a new subsection (ss) to require every hospital service corporation, medical expenses indemnity corporation or health service corporation providing medical coverage to carry coverage for ovarian cancer testing and screening.
Section 4 sets forth the effective date.
Justification
Ovarian cancer is the fifth most common cancer in women. According to Memorial Sloan Kettering, one in 70 women will develop ovarian cancer in her lifetime, and in 2008, more than 15,000 women died from it.(1)
Early detection and treatment are the keys to stopping this deadly disease. While there is no existing screening test for ovarian cancer, diagnostic tests are crucial for determining whether a patient experi- encing symptoms has ovarian cancer. No woman should have to forgo or delay testing because it is not covered by her insurer. This bill will ensure that alit insurers in New York State provide coverage for diag- nostic testing for ovarian cancer.
Prior legislative history
2019-20: S526/A3684 - Died in Insurance
2017-18: S1162/1745 - Died in Insurance
2015-16: S4730A/A917A - Died in Insurance
Fiscal implications
Minimal increase for state health plan.
Effective date
This act shall take effect on the first of January next succeeding the date on which it shall have become a law and shall apply to all policies issued, renewed, altered or modified on or after such effective date. (1)https://www.mskcc.org/cancer-care/types/ovarian/screening/ screen- ing-guidlines-ovarian (2)https://www.acog.org/womens-health/faqs/ovarian-cancer
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.